GlassScriptPrepare for your visit
Keanan Mcgonigle
Internal Medicine · Washington, DC · NPI 1326669664
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$482.14
in general payments reported to CMS, 2019-2025 · $216 in 2025
The $216 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Dexcom, INC. $113.32
- Exact Sciences Corporation $75.17
- Novo Nordisk INC $62.02
- Astellas Pharma US INC $61.14
- Inspire Medical Systems, INC. $50.90
- Dynavax Technologies Corporation $42.93
Drugs and devices associated with these payments
Dexcom G7 Gss (161) Cologuard Collection Kit Veozah Inspire Heplisav-B Ozempic Rybelsus Apretude Aptima Mounjaro
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Keanan Mcgonigle listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11445625/keanan-mcgonigle